Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism
Antoine Tabarin, … , J. Larry Jameson, Philippe Bouchard
Antoine Tabarin, … , J. Larry Jameson, Philippe Bouchard
Published February 1, 2000
Citation Information: J Clin Invest. 2000;105(3):321-328. https://doi.org/10.1172/JCI7212.
View: Text | PDF
Article Article has an altmetric score of 3

A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism

  • Text
  • PDF
Abstract

Mutations in the DAX1 gene cause X-linked adrenal hypoplasia congenita (AHC) and hypogonadotropic hypogonadism (HHG). In affected boys, primary adrenal insufficiency occurs soon after birth or during early childhood; HHG is recognized at the expected time of puberty. In this report, we describe the novel phenotype of a man who presented with apparently isolated adrenal insufficiency at 28 years of age. Examination revealed partial pubertal development and undiagnosed incomplete HHG. Gonadotropin therapy did not improve his marked oligospermia, suggesting a concomitant primary testicular abnormality. Genomic analysis revealed a novel missense mutation, I439S, in DAX1. The mutant DAX-1 protein was studied for its ability to function as a transcriptional repressor of target genes. Consistent with the patient’s mild clinical phenotype, the I439S mutation conferred intermediate levels of repressor activity of DAX-1 when compared with mutations associated with classic AHC. This unique case extends the clinical spectrum of AHC to include delayed-onset primary adrenal insufficiency in adulthood and milder forms of HHG. Furthermore, in accordance with findings in Ahch (Dax1) knockout mice, the clinical features in this patient suggest that DAX-1 function is required for spermatogenesis in humans, independent of its known effects on gonadotropin production.

Authors

Antoine Tabarin, John C. Achermann, Dominique Recan, Véronique Bex, Xavier Bertagna, Sophie Christin-Maitre, Masafumi Ito, J. Larry Jameson, Philippe Bouchard

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
Functional effects of the I439S DAX-1 mutant. (a) Schematic representati...
Functional effects of the I439S DAX-1 mutant. (a) Schematic representation of the DAX-1 mutant constructs studied. (b) The effect of wild-type DAX-1 and its mutants on basal transcriptional activity was studied using 25 ng of a pBIND vector containing the putative LBD (207–470) of DAX-1 fused to the GAL4 DBD, and 500 ng of a UAS-TK109luc reporter. Transient transfection studies were performed in triplicate using human tsa201 embryonic kidney cells. The mean of each triplicate reaction was expressed as a percentage of the empty vector (–) control for that study. The results represent the mean ± SEM from at least 6 independent triplicate experiments. (c) The effect of DAX-1 and its mutants on SF-1–mediated transactivation. Transfections were performed as above, using 25 ng of a pBINDGAL4 fusion protein containing the activation domain of SF-1 (FTZF1) (residues 133–461), 50 ng pCMX–DAX1 expression vector containing the full-length wild-type or mutant cDNA, and 500 ng of a UAS-TK109luc reporter. WT, wild type.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 Wikipedia pages
29 readers on Mendeley
See more details